123 related articles for article (PubMed ID: 35996957)
1. Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study.
Cao M; Li H; Sun D; He S; Yang F; Yan X; Zhang S; Zha Z; Zhou J; Luo P; Gong J; Ma H; Zhang S; Sun X; Xia C; Peng J; Chen W
Cancer; 2022 Oct; 128(20):3653-3662. PubMed ID: 35996957
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of liver cancer screening results and influencing factors of urban residents in Zhejiang Province from 2013 to 2018].
Wang YQ; Li HZ; Wang L; Zhu C; Sun XH; Zhang MZ; Jin L; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):346-352. PubMed ID: 33730826
[No Abstract] [Full Text] [Related]
3. Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme.
Lee EH; Han MA; Lee HY; Jun JK; Choi KS; Park EC
Asian Pac J Cancer Prev; 2010; 11(5):1305-10. PubMed ID: 21198282
[TBL] [Abstract][Full Text] [Related]
4. [Early diagnosis and early treatment for liver cancer in Qidong: survival of patients and effectiveness of screening].
Chen JG; Zhang YH; Zhu J; Lu JH; Wang JB; Sun Y; Xue XF; Lu LL; Chen YS; Wu Y; Jiang XP; Ding LL; Zhang QN; Zhu YR
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):946-951. PubMed ID: 29262514
[No Abstract] [Full Text] [Related]
5. Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.
Park B; Choi KS; Suh M; Shin JY; Jun JK
PLoS One; 2013; 8(6):e68315. PubMed ID: 23840846
[TBL] [Abstract][Full Text] [Related]
6. [Effect evaluation of the primary screening strategy for liver cancer in rural areas of China].
Cao MM; Li H; Zha ZQ; Zhou JY; Luo PF; Gong JY; Ma HM; Sun XB; Chen WQ
Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):990-996. PubMed ID: 36164703
[No Abstract] [Full Text] [Related]
7. [Compliance rate and impact factor analysis of liver cancer screening in urban areas of Henan Province].
Guo LW; Zhang SK; Liu SZ; Zheng LY; Chen Q; Cao XQ; Sun XB; Zhang JG
Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):233-237. PubMed ID: 33601491
[No Abstract] [Full Text] [Related]
8. Factors associated with attending the National Cancer Screening Program for liver cancer in Korea.
Noh DK; Choi KS; Jun JK; Lee HY; Park EC
Asian Pac J Cancer Prev; 2012; 13(2):731-6. PubMed ID: 22524852
[TBL] [Abstract][Full Text] [Related]
9. [Access to liver cancer screening and surveillance in populations in China: an exploratory analysis].
Shi JF; Cao MD; Yan XX; Cao MM; Wang YT; Li YJ; Wang X; Li JB; Li N; Qu CF; Chen WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):906-914. PubMed ID: 35725349
[No Abstract] [Full Text] [Related]
10. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Wun YT; Dickinson JA
Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
[TBL] [Abstract][Full Text] [Related]
12. Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China.
Ji M; Liu Z; Chang ET; Yu X; Wu B; Deng L; Feng Q; Wei K; Liang X; Lian S; Quan W; Wang P; Du Y; Liang Z; Xia S; Lin H; Li F; Cheng W; Chen W; Yuan Y; Ye W
Sci Rep; 2018 Aug; 8(1):12787. PubMed ID: 30143694
[TBL] [Abstract][Full Text] [Related]
13. Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.
Su F; Weiss NS; Beste LA; Moon AM; Jin GY; Green P; Berry K; Ioannou GN
J Hepatol; 2021 Apr; 74(4):850-859. PubMed ID: 33245934
[TBL] [Abstract][Full Text] [Related]
14. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
[No Abstract] [Full Text] [Related]
15. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.
Guo LW; Chen Q; Shen YC; Meng QC; Zheng LY; Wu Y; Cao XQ; Xu HF; Liu SZ; Sun XB; Qiao YL; Zhang SK
JAMA Netw Open; 2020 Nov; 3(11):e2019039. PubMed ID: 33141158
[TBL] [Abstract][Full Text] [Related]
16. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer.
Zhang B; Yang B
J Med Screen; 1999; 6(2):108-10. PubMed ID: 10444731
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with organized and opportunistic cancer screening: Results of the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2011.
Kang M; Yoo KB; Park EC; Kwon K; Kim G; Kim DR; Kwon JA
Asian Pac J Cancer Prev; 2014; 15(7):3279-86. PubMed ID: 24815483
[TBL] [Abstract][Full Text] [Related]
18. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
[TBL] [Abstract][Full Text] [Related]
19. [Family history of liver cancer increases the risk of liver cancer incidence: a 20-year prospective cohort study in Qidong, China].
Sun Y; Tu H; Lu P; Wang J; Wu Y; Zhang Q; Qian G; Chen T
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):752-6. PubMed ID: 25496865
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.
Park SH; Heo NY; Park JH; Kim TO; Yang SY; Kim HK; Moon YS; Kim CH; Suk KT; Kim DJ; Lee HY
Dig Dis Sci; 2012 Dec; 57(12):3258-64. PubMed ID: 22729598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
